Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

Maintaining product authenticity: The solution to a serial problem

Sales and Marketing |

Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …

Feature

Sidelined or streamlined? Diabetic care and COVID-19

Sales and Marketing |

The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …

Feature

Outsourcing in clinical trials: A response to rising challenges

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …

Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …

Feature

Debunking vaccine myths and growing concerns

Manufacturing and Production |

Before the COVID-19 pandemic, vaccines were never seen as a quick fix. Preventative vaccines for Ebola, malaria, and the Zika …

Feature
33482625641_c7347cbaba_h

AI and neurology: How machine learning is revolutionising neuroscience

Manufacturing and Production |

 

Feature

Medical cannabis: The next innovation in oncology?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp …

Feature
drugcosts-edt-jumbo

Pharma disputes, fines, and the work of the CMA

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …

Feature
pers

Personalised medicine in oncology: Where are we now?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …

Feature
close-up-of-female-hands-holding-medication-bottle-royalty-free-image-1612294037

Exploring the potential of drug repurposing

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | drug repurposing

Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …

Feature

Biosimilars and Brexit: What’s in store for UK’s biosimilar market?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biosimilars, brexit

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …

Feature

The importance of representation in clinical trials

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Representation, clinical trials

Before any kind of new medicine can be made available to the market, it has to go through a strictly …

Feature

Are we on the cusp of an AI revolution?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …

Feature

Navigating through the post-COVID-19 R&D bottleneck

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

Jack Goddard inve

Feature
1558469633615

The Truth Behind the £1.8 Million Drug

Manufacturing and Production | FDA, NHS, NICE

As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026